Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Clovis OncologyProQR TherapeuticsXeris PharmaceuticalsCV SciencesDynavax Technologies
SymbolNASDAQ:CLVSNASDAQ:PRQRNASDAQ:XERSOTCMKTS:CVSINASDAQ:DVAX
Price Information
Current Price$3.62$6.63$9.00$2.02$4.25
52 Week RangeHoldBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationHoldBuyBuyBuyBuy
Consensus Price Target$22.27$30.40$22.50$7.33$21.00
% Upside from Price Target515.27% upside358.81% upside150.00% upside263.04% upside394.12% upside
Trade Information
Market Cap$177.01 million$244.90 million$207.80 million$200.59 million$276.91 million
Beta1.860.15-0.44-0.410.46
Average Volume2,449,058206,532209,008878,4531,339,561
Sales & Book Value
Annual Revenue$95.39 millionN/A$2.46 million$48.24 million$8.20 million
Price / Sales2.07N/A98.734.1633.77
CashflowN/AN/AN/A$0.12 per shareN/A
Price / CashN/AN/AN/A16.88N/A
Book Value$2.78 per share$2.83 per share$3.61 per share$0.31 per share$1.01 per share
Price / Book1.30N/A2.496.524.21
Profitability
Net Income$-368,010,000.00$-43,570,000.00$-60,080,000.00$10 million$-158,900,000.00
EPS($7.07)($1.29)($4.99)$0.09($2.55)
Trailing P/E RatioN/AN/AN/A22.44N/A
Forward P/E RatioN/AN/AN/A15.54N/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-332.18%N/A-4,876.50%-3.29%-781.10%
Return on Equity (ROE)-372.68%-50.97%-107.65%-6.47%-304.71%
Return on Assets (ROA)-49.10%-41.92%-68.67%-4.65%-64.45%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio8.04%0.16%0.39%0.13%19.95%
Current Ratio3.57%9.51%6.00%3.20%4.30%
Quick Ratio3.32%9.51%6.00%2.43%3.47%
Ownership Information
Institutional Ownership Percentage91.69%60.79%62.44%0.10%80.80%
Insider Ownership Percentage8.30%N/A7.43%10.10%4.90%
Miscellaneous
EmployeesN/A1189078249
Shares Outstanding54.66 million38.87 million26.99 million99.30 million65.16 million
Next Earnings Date10/29/2019 (Estimated)11/6/2019 (Estimated)11/6/2019 (Estimated)11/6/2019 (Estimated)11/4/2019 (Estimated)
OptionableOptionableOptionableNot OptionableNot OptionableOptionable
 Clovis OncologyProQR TherapeuticsXeris PharmaceuticalsCV SciencesDynavax Technologies

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel